Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial-Reference-Cited by-同舟云学术

Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial

Published:2021-11-27 Issue: Volume: Page:
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol.

Author:

Lijffijt Marijn,Murphy Nicholas^ORCID,Iqbal Sidra,Green Charles E.,Iqbal Tabish,Chang Lee C.,Haile Colin N.,Hirsch Lorna C.,Ramakrishnan Nithya,Fall Dylan A.,Swann Alan C.,Al Jurdi Rayan K.,Mathew Sanjay J.^ORCID

Funder

U.S. Department of Veterans Affairs

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

https://www.nature.com/articles/s41386-021-01242-9.pdf

Reference47 articles.

1. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163:28–40.

2. Nelson JC, Delucchi K, Schneider LS. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence. Am J Geriatr Psychiatry. 2008;16:558–67.

3. Zanardi R, Cusin C, Rossini D, De Ronchi D, Serretti A. Comparison of response to fluvoxamine in nondemented elderly compared to younger patients affected by major depression. J Clin Psychopharmacol. 2003;23:535–9.

4. Tedeschini E, Levkovitz Y, Iovieno N, Ameral VE, Nelson JC, Papakostas GI. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. J Clin Psychiatry. 2011;72:1660–8.

5. Beekman ATF, Copeland J, Prince MJ. Review of community prevalence of depression in later life. Br J Psychiatry. 1999;174:307–11.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-improvement predicts subsequent non-response to repeated-dose intravenous ketamine for depression: a re-analysis of a 2-week open-label study in patients with unipolar and bipolar depression;Translational Psychiatry;2024-08-06

2. The clinical perspective on late-onset depression in European real-world treatment settings;European Neuropsychopharmacology;2024-07

3. Ketamine in the effective management of chronic pain, depression, and posttraumatic stress disorder for Veterans: A meta-analysis and systematic review;Frontiers in Psychiatry;2024-06-24

4. Storm on predictive brain: A neurocomputational account of ketamine antidepressant effect;Neuroscience & Biobehavioral Reviews;2023-11

5. Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies;The Lancet Psychiatry;2023-10